Haleon Selects Salesforce Agentforce Life Sciences Cloud for Customer Engagement to Improve Engagement with Pharmacies and Healthcare Professionals with AI

Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world's #1 AI CRM, today announced that Haleon will leverage Salesforce to drive more effective engagement with pharmacies and healthcare professionals worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251008924109/en/

A pharmacist advises a consumer on the purchase of Haleon's Otrivin nasal mist.

A pharmacist advises a consumer on the purchase of Haleon's Otrivin nasal mist.

Haleon has chosen Salesforce Life Sciences Cloud for Customer Engagement , Data Cloud , and Agentforce to support its 4,500-strong sales force globally. The AI-powered solution will enable the global consumer healthcare company to have more productive customer interactions, deepening its relationships with pharmacists and healthcare professionals around the world. This should serve to benefit millions of consumers globally by giving more people better access to everyday healthcare products.

With Salesforce, Haleon's sales representatives will spend less time on administrative tasks and have access to data-driven insights on consumer demographics, shopping trends, and point-of-sale marketing. This will enable Haleon's sales representatives to focus their efforts on value-add activities such as bespoke activation plans for their customers.

Additionally, Haleon, maker of category leading brands like Sensodyne, Voltaren, and Centrum, will serve as a design partner for Salesforce Life Sciences Cloud for Customer Engagement. In this role, Haleon will influence the development of Salesforce's life sciences solutions to further address the specific needs of the consumer health industry, including by supporting product availability, shelf-life management, promotions, and inventory management across global retail and online channels.

"We are excited to partner with Salesforce to bring more effective, data-driven insights to our customers. This selection of Life Sciences Cloud and Agentforce will enable pharmacists and healthcare professionals to more efficiently deliver better everyday health to millions of people all around the world," commented Claire Dickson, Chief Digital and Technology Officer at Haleon.

Dickson continued, "We are also delighted to advise Salesforce on the development of the consumer health capabilities of the platform. We are committed to shaping the future of our industry and look forward to impacting the development of tools that will help support the growth of all our categories."

"Haleon's adoption of our next-generation Life Sciences Cloud for Customer Engagement and Agentforce will reimagine how the consumer health industry engages with pharmacies and HCPs through real-time insights and trusted AI," said Frank Defesche, General Manager of Life Sciences at Salesforce. "Their insights ensure we're meeting the complex, specific needs of the consumer healthcare industry without having to customize solutions - all while promoting greater productivity, innovation, and wellness."

Notes to Editors:

Learn more:

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com

About Salesforce

Salesforce helps organizations of any size reimagine their business for the world of AI. With Salesforce's trusted platform and Agentforce, organizations can bring humans together with agents to drive customer success—powered by AI, data, and action. With its long-standing history powering the healthcare industry, Salesforce continues to be invested in driving healthier outcomes for pharma and medtech organizations. Visit www.salesforce.com for more information.

Order Management is expected to be available as a part of Life Sciences Cloud for Customer Engagement starting October 2026. Any unreleased services or features referenced here are not currently available and may not be delivered on time or at all. Customers should make their purchase decisions based upon features that are currently available.

Haleon PR Contact:
Gemma Thomas
gemma.x.thomas@haleon.com

Salesforce PR Contact:
Maha Neouchy
pr@salesforce.com

News Provided by Business Wire via QuoteMedia

CRM
The Conversation (0)
Quimbaya Identifies Mineralized High-Sulfidation Porphyry System at Surface at Tahami

Quimbaya Identifies Mineralized High-Sulfidation Porphyry System at Surface at Tahami

Surface work confirms Cu-Mo-Au mineralization, classic porphyry type style-alteration, and active gold workings, reinforcing district-scale upside at Quimbaya's flagship project in Colombia. NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES... Keep Reading...
Silver47 Completes Successful Red Mountain Drill Program and Intersects Massive Sulfides in Multiple Holes

Silver47 Completes Successful Red Mountain Drill Program and Intersects Massive Sulfides in Multiple Holes

The Red Mountain Deposit Remains Open to Expansion in Multiple Directions with Assays PendingSilver47 Exploration Corp. (TSXV: AGA,OTC:AAGAF) (OTCQB: AAGAF) ("Silver47" or the "Company") is pleased to announce the completion of its summer 2025 drill program at its wholly-owned Red Mountain... Keep Reading...
Allied Critical Metals Expands High Grade Footprint at Borralha Tungsten Project

Allied Critical Metals Expands High Grade Footprint at Borralha Tungsten Project

New Step-Out and Infill Results Build Confidence in Resource Growth and Model Robustness Allied Critical Metals Inc. (CSE: ACM,OTC:ACMIF) (OTCQB: ACMIF) (FSE: 0VJ0) ("Allied" or the "Company"), which is focused on its 100% owned past producing Borralha and Vila Verde tungsten projects in... Keep Reading...
GreenRoc Strategic Materials

EU Commissioner Dan Jørgensen to visit Amitsoq

GreenRoc Strategic Materials Plc (AIM: GROC), a company focused on the development of critical mineral projects in Greenland, is pleased to announce that the European Union ("EU") Commissioner for Energy, Dan Jørgensen, will be visiting GreenRoc's Amitsoq graphite deposit and planned mine site... Keep Reading...
Allied Critical Metals Announces Highlights from the 2023-24 Borralha Drill Program

Allied Critical Metals Announces Highlights from the 2023-24 Borralha Drill Program

Highlights from 2023-24 Drill Program* include: From Bo_RC_12: 5.79% WO₃ over 2.0 metres (182-184m) 1.12% WO₃ over 4.0 metres (246-250m, within 12m from 82m to 94m of 0.40%) 0.78% WO₃ over 12.0 metres (82-94m, within 20m from 82m to 102m of 0.50%) 0.50% WO₃ over 20.0 metres (82-102m) From... Keep Reading...

Latest Press Releases

Related News